Senior Scientist, Clinical Pharmacology & Quantitative Science
Genmab
About this role
Genmab is seeking a Quantitative Systems Pharmacology (QSP) Modeler to lead the development and implementation of mathematical models that support the development of antibody-based therapies for cancer and serious diseases. The role involves collaborating with various teams, utilizing modeling software, and applying advanced mathematical and data-driven methods to inform drug development and dose selection.
Skills
About Genmab
genmab.comGenmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Recent company news
MarketBeatFirst Trust Advisors LP Sells 82,922 Shares of Genmab A/S Sponsored ADR $GMAB
11 hours ago
MorningstarNarrow-Moat Genmab's Royalty Revenue Maintains Near-Term Growth as Pipeline Advancement Progresses
3 days ago
GlobeNewswireTransactions in Connection with Share Buy-back Program
3 days ago
TipRanksGenmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Yahoo FinanceGenmab Publishes 2025 Annual Report
3 weeks ago
About Genmab
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Genmab.
Salary
$139k – $208k
per year
More jobs at Genmab
Similar Jobs
Principal Scientist - Clinical Pharmacology, Modeling & Simulation
Amgen
Associate Director, Quantitative Pharmacology
Regeneron Pharmaceuticals
Quantitative Systems Pharmacology Modeler - all genders
Sanofi
Senior Scientist - Clinical Pharmacology (m/f/d)
tubulis
Director, Clinical Pharmacology & Quantitative Pharmacology (CPQP)- Oncology
American Association of Physicists in Medicine
Manager, Clinical Pharmacology
Revolution Medicines